Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study

Table 1

Antiplatelet (AP) and anticoagulant (AC) use both in-hospital and postdischarge.

	In-hospital	Postdischarge
DAP	4165 (78.7%)	4091 (77.3%)
SAP	1012 (19.1%)	1077 (20.3%)
No AP	117 (2.2%)	126 (2.4%)
AC	5264 (99.4%)	475 (9.0%)
No AC	30 (0.6%)	4819 (91.0%)
Triple therapy (DAP + AC)	4155 (78.5%)	273 (5.2%)

Note: DAP: dual antiplatelet; SAP: single antiplatelet.